title: Gender-specific differences of serum leptin in obese and normal-weight adolescents: studies in type-I diabetes and Turner syndrome.
abstract: The influence of exogenous insulin and estrogen substitution on serum leptin-like immunoreactivity was studied longitudinally in patients with type-I diabetes and Turner syndrome using a specific radioimmunoassay. Prepubertal, pubertal and postpubertal samples of 17 patients (9 girls, 8 boys) with type-I diabetes mellitus developing obesity were compared to those of 17 normal-weight controls matched for gender, age and diabetes duration. Six obese and six normal-weight girls with Turner syndrome were studied without hormone substitution, with ethinylestradiol alone, and with cyclic estradiol/gestagen substitution. The mean leptin levels of the girls with diabetes were two times higher than boys at all times, while insulin doses and glycemic control had no influence. In Turner syndrome estrogen substitution led to increased leptin levels only in the obese group. This study revealed that both body weight above normal and female sex steroids seem to be necessary to elevate leptin concentrations, while exogenous insulin has no effect.
authors.affiliation: Abteilung für Allgemeine Pädiatrie, Kliniken für Kinderheilkunde und Kinderchirurgie, Charité-Virchow-Klinikum, Berlin, Deutschland. tdanne@ukrv.de
authors.forename: T
authors.initials: T
authors.lastname: Danne
authors.forename: A
authors.initials: A
authors.lastname: Grüters
authors.forename: A
authors.initials: A
authors.lastname: Wladimirova
authors.forename: B
authors.initials: B
authors.lastname: Weber
authors.forename: R
authors.initials: R
authors.lastname: Horn
authors.forename: B
authors.initials: B
authors.lastname: Mayr
authors.forename: G
authors.initials: G
authors.lastname: Brabant
mesh_terms: D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D020738:Leptin / Q000097:blood*; D008137:Longitudinal Studies; D008297:Male; D009765:Obesity / Q000097:blood* / Q000150:complications; D012737:Sex Factors; D014424:Turner Syndrome / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D004967:Estrogens; D007328:Insulin; D020738:Leptin